BACKGROUND: Aesthetic treatment of the lower face is increasingly in demand, particularly owing to age-related changes in appearance. VYC-25L is a novel hyaluronic acid filler with high G' and high cohesivity, specifically designed for sculpting and contouring of the chin and jaw. OBJECTIVE: To assess the use of grid traced onto the chin and jaw for guiding treatment with VYC-25L. METHODS: This was a retrospective, single-center analysis of data from adult patients undergoing treatment of the lower third of the face with VYC-25L. A grid system of horizontal and vertical lines was used to systematize the process of treatment planning and performance. RESULTS: Thirty subjects were enrolled (53.3% female; mean age, 34.4 ± 2.8 years). The mean quantity of VYC-25L used was 4.0 ± 0.8 mL. Using the 5-point Global Aesthetic Improvement Scale, 29 patients (96.7%) rated their appearance at 20 days post-treatment as 'much improved' or 'very much improved'. The only complications recorded were early transient soft-tissue edema (n=14; 46.7%) and bruising (n=6; 20.0%). There were no cases of infection, paresthesia, asymmetry, hematoma, necrosis, or skin discoloration. CONCLUSIONS: Treatment of the chin and jawline with VYC-25L, using a grid-based standardized approach, appears to be effective and safe with high rates of patient satisfaction. It offers a potentially high-impact approach for patients across a variety of biologic and economic circumstances.
BACKGROUND: Aesthetic treatment of the lower face is increasingly in demand, particularly owing to age-related changes in appearance. VYC-25L is a novel hyaluronic acid filler with high G' and high cohesivity, specifically designed for sculpting and contouring of the chin and jaw. OBJECTIVE: To assess the use of grid traced onto the chin and jaw for guiding treatment with VYC-25L. METHODS: This was a retrospective, single-center analysis of data from adult patients undergoing treatment of the lower third of the face with VYC-25L. A grid system of horizontal and vertical lines was used to systematize the process of treatment planning and performance. RESULTS: Thirty subjects were enrolled (53.3% female; mean age, 34.4 ± 2.8 years). The mean quantity of VYC-25L used was 4.0 ± 0.8 mL. Using the 5-point Global Aesthetic Improvement Scale, 29 patients (96.7%) rated their appearance at 20 days post-treatment as 'much improved' or 'very much improved'. The only complications recorded were early transient soft-tissue edema (n=14; 46.7%) and bruising (n=6; 20.0%). There were no cases of infection, paresthesia, asymmetry, hematoma, necrosis, or skin discoloration. CONCLUSIONS: Treatment of the chin and jawline with VYC-25L, using a grid-based standardized approach, appears to be effective and safe with high rates of patient satisfaction. It offers a potentially high-impact approach for patients across a variety of biologic and economic circumstances.
Authors: María A Segurado; Fernando Urdiales-Gálvez; Paula A Benítez; Sara Carrasco; Iratxe Díaz; Nuria Escoda; Lisandro Farollch-Prats; Vitor Figueiredo; Francisco Ortíz; María Consuelo Sebastián; Luís Uva Journal: J Cosmet Dermatol Date: 2021-08-30 Impact factor: 2.189
Authors: Raffaele Rauso; Luigi Rugge; Fabrizio Chirico; Giovanni Francesco Nicoletti; Romolo Fragola; Pierfrancesco Bove; Nicola Zerbinati; Giorgio Lo Giudice Journal: Dermatol Pract Concept Date: 2022-07-01